Effects of cyclosporine A on deformability and oxidative stress in the peripheral lymphocytes of rats

Clinical Hemorheology and Microcirculation

Volumn 36, Issue 1, 2007, Pages 75-81

  Tamer, Sule ^a   Ademoglu, Evin ^a   Gokkusu, Cahide ^a   Albeniz, Isil ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cyclosporine A; Deformability; Oxidative stress and lymphocytes

Indexed keywords

CYCLOSPORIN A; LIPID PEROXIDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; THIOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL LEVEL; CONTROLLED STUDY; CYTOTOXICITY; DATA ANALYSIS; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; LIPID PEROXIDATION; LYMPHOCYTE STRUCTURE; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL LYMPHOCYTE; RAT; RISK FACTOR;

ANIMALS; CELL SHAPE; CYCLOSPORINE; FEMALE; HEMORHEOLOGY; LEUKOCYTE COUNT; LIPID PEROXIDATION; LYMPHOCYTES; NITRIC OXIDE; OXIDATIVE STRESS; RANDOM ALLOCATION; RATS; RATS, WISTAR; SULFHYDRYL COMPOUNDS; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 33846049163     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. D. Andrés, N. Sanz, A. Zaragoza, A.M Alvarez et al., Changes in antioxidant defence systems induced by cyslosporin A in culture of hepatocytes from 2- and 12-month-old rats, Biochem. Pharmacol. 59 (2000), 1091-1100.
2. J. Liu, J.D. Farmer, W.S. Lane, J. Friedman et al., Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes, Cell 66 (1991), 807-811.
3. P.S. Mattila, K.S. Ullman, S. Fieringand, E.A. Emmel et al., The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes, EMBO J. 9 (1990), 4425-4433.
4. R. R. Thakkar, O.L. Wang, M. Zerouga, W. Stillwell et al., Docosahexaenoic acid reverse cyclosporin A-induced membrane structure and function, Biochem. Biophys. Acta 1474 (2000), 183-195.
5. A.I. Galan, M.E. Munoz and R. Jimenez, S-Adenosylmethionine protects against cyclosporin A-induced alterations in rat liver plasma membrane fluidity and functions, J. Pharmacol. Exp. Ther. 290 (1999), 774-781.
6. A. Fogo, Cyclosporine toxicity, Am. J. Kidney Dis. 36 (2000), E1.
7. B. Longoni, L. Giovannini, M. Migliori, A.A. Bertelli et al., Cyclosporine-induced lipid peroxidation and propionyl carnitine protective effect, Int. J. Tissue React. 21 (1999), 7-11.
8. T. Zima, V. Tesar, S. Stipek, J. Crkovska et al., The influence of cyclosporine on lipid peroxidation and superoxide dismutase in adriamycine nephropathy in rats, Nephron 75 (1997), 464-468.
9. Z. Zhong, G.E. Arteel, H.D. Connor and M. Yin, Cyclosporin A increases hypoxia and free radical production in rat kidneys: prevention by dieatry glycine, Am. J. Physiol. 275 (1998), 595-604.
10. C. Wang and A.K. Salahudeen, Lipid peroxidation accompanies cyclosporine nephrotoxicity: effect of vitamin E, Kidney Int. 47 (1995), 927-934.
11. M.J. Brown, J. Hallam, E.C. Guyon and F.S. Shaw, Rigiditiy of circulating lymhpocytes is primarily confered by vimentin intermediate filaments, J. Immunol. 166 (2001), 6640-6646.
12. W.H. Reinhart, S. Usami, E.A. Schmalzer and M.M.L. Lee, Evaluation of red blood cell filterability test: Influences of pore size, haematocrit level and flow rate, J. Lab. Clin. Med. 104 (1984), 501-516.
13. W. Wasowic, J. Neve and A. Peretz, Optimised steps in fluorometric determination of thiobarbituric acid-reactive substance in serum: Importance of extraction pH and influence of sample preservation and storage, Clin. Chem. 39 (1993), 2522-2526.
14. Y. Sun and L.W. Oberley, Suitability of coper chloride as a reaction terminator for superoxide dismutase activity assay, Clin. Chim. Acta 226 (1994), 101-103.
15. M.L. Hu, Measurement of protein thiol groups and glutathione in plasma, Method Enzymol. 233 (1994), 380-385.
16. C.D. Niebylski and H.R. Petyy, Cyclosporine A induces an early and transient rigidification of lymphocyte membranes, J. Leukoc. Biol. 49 (1991), 407-411.
17. G. Inselman, H.U. Lawerenz, U. Nellessen and H.T. Heidemann, Enhancement of cyclosporin A induced hepato- and nephrotoxicity by glutathione deplation, Eur. J. Clin. Invest. 24 (1994), 355-359.
18. L. Calo, A. Semplicini, P.A. Davis and P. Bonvicini, Cyclosporin-induced endothelial dysfunction and hypertension: are nitric oxide system abnormality and oxidative stres involved? Transpl. Int. 13 (2000), 413-418.
19. C.S. Kwak, K.C. Munand and S.I. Suh, Production of oxygen free radicals and hemolysis by cyclosporin, Transplant. Proc. 34 (2002), 2654-2655.
20. L.A. Lexis, R.S. Richards, R.G. Fassett and J.S. Coombes, Cyclosporine A-induced changes to erythrocyte redox balance is time course-dependent, Basic Clin. Pharmacol. Toxicol. 97 (2005), 135-140.
21. V. Chander and K. Chopra, Nifedipine attenuates changes in nitric oxide levels, renal oxidative stress, and nephrotoxicity induced by cyclosporine, Ren. Fail. 27 (2005), 441-450.
22. H. Sies, Glutathione and its role in cellular functions, Free Radic. Biol. Med. 27 (1999), 916-921.
23. V.A. Duruibe, A. Okonomah and G.T. Blyden, Effect of cyclosporin on rat liver and kidney glutathione content, Pharmacology 39 (1989), 205-214.
24. L.A. Lexis, A. Fenning, L. Brown and R.G. Fassett, Antioxidant supplementation enhances erythrocyte antioxidant status and attenuates cyclosporine-induced vascular dysfunction, Am. J. Transplant. 6 (2006), 41-49.
25. L.A. Lexis, R.G. Fassett and J.S. Coombes, Alpha-tocopherol and alpha-lipoic acid enhance the erythrocyte antioxidant defence in cyclosporine A-treated rats, Basic Clin. Pharmacol. Toxicol. 98 (2006), 68-73.
26. T. Parra Cid, J.R. Conejo Garcia, F. Rballo Alverez and G. De Arriba, Antioxidant nutrients protect against cyclosporine A nephrotoxicity, Toxicology 189 (2003), 99-111.